Biologics & Biosimilars Market Size, COVID-19 Impact Analysis By Regional Outlook (Europe, North America, Asia Pacific, Middle East & Africa And South America), Growth Potential, Price Trends, Competitive Market Share & Forecast 2023 - 2028 (Updated Version Available)
Biologics & Biosimilars Market Size, COVID-19 Impact Analysis By Regional Outlook (Europe, North America, Asia Pacific, Middle East & Africa And South America), Growth Potential, Price Trends, Competitive Market Share & Forecast 2023 - 2028 (Updated Version Available)
ID : MRI22624 | Date : Jan, 2021 | Pages :
186 | Region : Global |
Publisher : RI
The Biologics & Biosimilars market report provides a detailed analysis of global market size, value chain optimization, segmentation market growth, market share, competitive Landscape, regional and country-level market size, sales analysis, impact of domestic and global market players, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Biologics & Biosimilars market size is expected to gain market growth in the forecast period of 2020 to 2028, with a CAGR of xx%% in the forecast period of 2020 to 2028 and will expected to reach USD xx million by 2028, from USD xx million in 2020.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Antibiotic
Enzyme
Hormone
Non-Patented Biological Reagents
Other
By Application
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
Competitive Landscape and Biologics & Biosimilars Market Share Analysis
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
fizer
Roche
Amgen
AbbVie
Sanofi
Johnson & Johnson
Novo Nordisk
Novartis
Merck
Lilly
3sbio
Changchun High Tech
CP Guojian Pharmacy
Biotech Pharma
Gelgen Biopharma
Sandoz
Teva
Hospira
Mylan
Biologics & Biosimilars competitive landscape provides details by vendors, including company overview, company total revenue (financial), market potential, global presence, Biologics & Biosimilars sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Biologics & Biosimilars sales, revenue and market share for each player covered in this report.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Biologics & Biosimilars market presented in the report. This section sheds light on the sales growth of different regional and country-level Biologics & Biosimilars markets. For the historical and forecast period 2015 to 2028, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Biologics & Biosimilars market.
Region Coverage (Regional Production, Demand & Forecast by Countries etc.): North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Biologics & Biosimilars market for the forecast period 2020 - 2028?
• What are the driving forces in the Biologics & Biosimilars market for the forecast period 2020 - 2028?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Biologics & Biosimilars industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?
Table of Contents
1 Study Coverage
1.1 Biologics & Biosimilars Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Biologics & Biosimilars Market Size Growth Rate by Product
1.4.2 Antibiotic
1.4.3 Enzyme
1.4.4 Hormone
1.4.5 Non-Patented Biological Reagents
1.4.6 Other
1.5 Market by End User
1.5.1 Global Biologics & Biosimilars Market Size Growth Rate by End User
1.5.2 Tumor
1.5.3 Diabetes
1.5.4 Cardiovascular
1.5.5 Hemophilia
1.5.6 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Biologics & Biosimilars Market Size
2.1.1 Global Biologics & Biosimilars Revenue 2015-2028
2.1.2 Global Biologics & Biosimilars Sales 2015-2028
2.2 Biologics & Biosimilars Growth Rate by Regions
2.2.1 Global Biologics & Biosimilars Sales by Regions
2.2.2 Global Biologics & Biosimilars Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Biologics & Biosimilars Sales by Manufacturers
3.1.1 Biologics & Biosimilars Sales by Manufacturers
3.1.2 Biologics & Biosimilars Sales Market Share by Manufacturers
3.1.3 Global Biologics & Biosimilars Market Concentration Ratio (CR5 and HHI)
3.2 Biologics & Biosimilars Revenue by Manufacturers
3.2.1 Biologics & Biosimilars Revenue by Manufacturers (2015-2020)
3.2.2 Biologics & Biosimilars Revenue Share by Manufacturers (2015-2020)
3.3 Biologics & Biosimilars Price by Manufacturers
3.4 Biologics & Biosimilars Manufacturing Base Distribution, Product Types
3.4.1 Biologics & Biosimilars Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Biologics & Biosimilars Product Type
3.4.3 Date of International Manufacturers Enter into Biologics & Biosimilars Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Biologics & Biosimilars Sales by Product
4.2 Global Biologics & Biosimilars Revenue by Product
4.3 Biologics & Biosimilars Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Biologics & Biosimilars Breakdown Data by End User
6 North America
6.1 North America Biologics & Biosimilars by Countries
6.1.1 North America Biologics & Biosimilars Sales by Countries
6.1.2 North America Biologics & Biosimilars Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Biologics & Biosimilars by Product
6.3 North America Biologics & Biosimilars by End User
7 Europe
7.1 Europe Biologics & Biosimilars by Countries
7.1.1 Europe Biologics & Biosimilars Sales by Countries
7.1.2 Europe Biologics & Biosimilars Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Biologics & Biosimilars by Product
7.3 Europe Biologics & Biosimilars by End User
8 Asia Pacific
8.1 Asia Pacific Biologics & Biosimilars by Countries
8.1.1 Asia Pacific Biologics & Biosimilars Sales by Countries
8.1.2 Asia Pacific Biologics & Biosimilars Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Biologics & Biosimilars by Product
8.3 Asia Pacific Biologics & Biosimilars by End User
9 Central & South America
9.1 Central & South America Biologics & Biosimilars by Countries
9.1.1 Central & South America Biologics & Biosimilars Sales by Countries
9.1.2 Central & South America Biologics & Biosimilars Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Biologics & Biosimilars by Product
9.3 Central & South America Biologics & Biosimilars by End User
10 Middle East and Africa
10.1 Middle East and Africa Biologics & Biosimilars by Countries
10.1.1 Middle East and Africa Biologics & Biosimilars Sales by Countries
10.1.2 Middle East and Africa Biologics & Biosimilars Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Biologics & Biosimilars by Product
10.3 Middle East and Africa Biologics & Biosimilars by End User
11 Company Profiles
11.1 fizer
11.1.1 fizer Company Details
11.1.2 Company Business Overview
11.1.3 fizer Biologics & Biosimilars Sales, Revenue and Gross Margin (2015-2020)
11.1.4 fizer Biologics & Biosimilars Products Offered
11.1.5 fizer Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Company Business Overview
11.2.3 Roche Biologics & Biosimilars Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Roche Biologics & Biosimilars Products Offered
11.2.5 Roche Recent Development
11.3 Amgen
11.3.1 Amgen Company Details
11.3.2 Company Business Overview
11.3.3 Amgen Biologics & Biosimilars Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Amgen Biologics & Biosimilars Products Offered
11.3.5 Amgen Recent Development
11.4 AbbVie
11.4.1 AbbVie Company Details
11.4.2 Company Business Overview
11.4.3 AbbVie Biologics & Biosimilars Sales, Revenue and Gross Margin (2015-2020)
11.4.4 AbbVie Biologics & Biosimilars Products Offered
11.4.5 AbbVie Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Company Business Overview
11.5.3 Sanofi Biologics & Biosimilars Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Sanofi Biologics & Biosimilars Products Offered
11.5.5 Sanofi Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Company Business Overview
11.6.3 Johnson & Johnson Biologics & Biosimilars Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Johnson & Johnson Biologics & Biosimilars Products Offered
11.6.5 Johnson & Johnson Recent Development
11.7 Novo Nordisk
11.7.1 Novo Nordisk Company Details
11.7.2 Company Business Overview
11.7.3 Novo Nordisk Biologics & Biosimilars Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Novo Nordisk Biologics & Biosimilars Products Offered
11.7.5 Novo Nordisk Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Company Business Overview
11.8.3 Novartis Biologics & Biosimilars Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Novartis Biologics & Biosimilars Products Offered
11.8.5 Novartis Recent Development
11.9 Merck
11.9.1 Merck Company Details
11.9.2 Company Business Overview
11.9.3 Merck Biologics & Biosimilars Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Merck Biologics & Biosimilars Products Offered
11.9.5 Merck Recent Development
11.10 Lilly
11.10.1 Lilly Company Details
11.10.2 Company Business Overview
11.10.3 Lilly Biologics & Biosimilars Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Lilly Biologics & Biosimilars Products Offered
11.10.5 Lilly Recent Development
11.11 3sbio
11.12 Changchun High Tech
11.13 CP Guojian Pharmacy
11.14 Biotech Pharma
11.15 Gelgen Biopharma
11.16 Sandoz
11.17 Teva
11.18 Hospira
11.19 Mylan
12 Future Forecast
12.1 Biologics & Biosimilars Market Forecast by Regions
12.1.1 Global Biologics & Biosimilars Sales Forecast by Regions 2021-2028
12.1.2 Global Biologics & Biosimilars Revenue Forecast by Regions 2021-2028
12.2 Biologics & Biosimilars Market Forecast by Product
12.2.1 Global Biologics & Biosimilars Sales Forecast by Product 2021-2028
12.2.2 Global Biologics & Biosimilars Revenue Forecast by Product 2021-2028
12.3 Biologics & Biosimilars Market Forecast by End User
12.4 North America Biologics & Biosimilars Forecast
12.5 Europe Biologics & Biosimilars Forecast
12.6 Asia Pacific Biologics & Biosimilars Forecast
12.7 Central & South America Biologics & Biosimilars Forecast
12.8 Middle East and Africa Biologics & Biosimilars Forecast
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Biologics & Biosimilars Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Research Methodology
The Market Reports Insights offers numerous solutions and its full addition in the research methods to be skilled at each step. We use wide-ranging resources to produce the best outcome for our customers. The achievement of a research development is completely reliant on the research methods implemented by the company. We always faithful to our clients to find opportunities by examining the global market and offering economic insights.
Market Reports Insights are proud of our widespread coverage that encompasses the understanding of numerous major industry domains. Company offers consistency in our research report, we also offers on the part of the analysis of forecast across a range of coverage geographies and coverage. The research teams carry out primary and secondary research to carry out and design the data collection methods.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
Well researched, expertise analysts, well organized, concrete and current topics delivered in time.
- President and CEO
Very helpful to understand overview of business status, by customers, categories, timeless, and regions. Able to build the future business strategy on the basis of research report. Validated and researched information of reports.
- Senior Manager, Product Development
We are very thankful to (company name) for detailed research report delivering in short period of time. Good market research Company really commendable.
- Senior Manager, Product Development
Excellent services, unique and very professional. The effort taken to make sure relevance to our requirements ensured the best possible outcome.